On the right track ? Two Covid-19 vaccine projects, one British and one Chinese, have produced an important immune response and demonstrated their safety for patients, according to the results of two separate clinical trials, published this Monday in the British medical journal The Lancet .
The first, developed by the University of Oxford in partnership with AstraZeneca, generated "a strong immune response" in a trial on more than 1,000 patients, while the second, supported by CanSino Biologics, caused a strong reaction in terms antibody in another trial in most of the approximately 500 participants.
- Covid 19
- Vaccine
- Coronavirus
- Health